Becker's Healthcare April 3, 2024
Paige Twenter

The FDA has authorized the nation’s first AI-powered sepsis detection tool, artificial intelligence company Prenosis said April 3.

Clinicians have long been searching for — and testing — detection tools for sepsis, a life-threatening condition that at least 1.7 million adults in the U.S. develop each year. One in three patients who die in hospitals had sepsis during their stay, according to the CDC.

The authorized device is Sepsis Immunoscore, a machine learning software that integrates with hospital EHRs, according to a Prenosis news release. It uses 22 parameters to evaluate a patient’s biological status, calculate a sepsis risk score and four discrete risk categories, and display the results. The tool is not an alert system.

Many...

Today's Sponsors

Venturous
Got healthcare questions? Just ask Transcarent

Today's Sponsor

Venturous

 
Topics: AI (Artificial Intelligence), FDA, Govt Agencies, Provider, Technology
FDA Approves First Biosimilar of Xolair
Opinion: STAT+: How will the Center for Biologics Evaluation and Research change under RFK Jr.?
How the FDA Opens the Door to Risky Chemicals in America’s Food Supply
FDA OKs First Gene Therapy Implant for a Rare Eye Disease
Gene Therapy in an Implant: Neurotech Lands First FDA Approval in Rare Vision Disorder

Share This Article